In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis
Journal of Antimicrobial Chemotherapy · 2025
DOI: 10.1093/jac/dkaf064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Sujuan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricu…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Streptococcus suis, Diterpenes, Streptococcal Infections. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Key R&D Program Project Drug Target Discovery and New Veterinary Drug Creation.
Abstract (Originalsprache)
Objectives
To evaluate the in vitro and in vivo antimicrobial activity of pleuromutilin derivatives modified with C14 side-chain against Streptococcus suis.
Methods
To determine the minimum inhibitory concentrations (MICs) of 268 pleuromutilin derivatives with C14 side-chain modifications against S. suis ATCC 43 765 using the broth dilution method. Derivative B43, B49, B52, B53 and B54, which exhibited better antimicrobial activity, were selected for further investigation of their in vitro antibacterial effect, cytotoxicity, and in vivo antibacterial effect.
Results
Determination activity of five derivatives against clinical strains (n = 37), as well as growth and time-killing curves. Those experiments showed that all the five derivatives had good activity against S. suis in vitro. Resistance-inducing assays demonstrated that, except for B43, the derivatives had similar abilities to induce resistance to tiamulin. In addition, the five derivatives did not have erythrocyte haemolytic toxicity (0.25–16 mg/L) and cytotoxicity (1.25–80 mg/L). In the mouse thigh infection model, the derivative of B49 exhibited superior antibacterial efficacy. About 40 mg/kg B49 had good activity and improved the survival rate of mice by 33.3% in the S. suis mouse peritonitis model. Molecular docking study and scanning electron microscopy revealed that B49 can effectively bind to the active site of the 50S ribosome and disrupt cell membranes.
Conclusions
A total of 68.66% of the 268 C14 side-chain modified pleuromutilin derivatives showed potent activity against S. suis. Among them, B49 showed good in vitro and in vivo antimicrobial effects against S. suis, indicating that B49 can be intensively studied as an antimicrobial candidate compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, P.R.China.
- National Laboratory of Safety Evaluation (Environmental Assessment) of Veterinary Drugs, South China Agricultural University, Guangzhou 510642, P.R.China.
- China National Risk Assessment Laboratory for Antimicrobial Resistance of Animal Original Bacteria, South China Agricultural University, Guangzhou 510642, P.R.China.
- Zhaoqing Academy of Agricultural and Forestry Sciences, Zhaoqing 526040, P.R.China.
ORCID-Profile: Honghao Huang, Youzhi Tang
Förderung
- National Key R&D Program Project Drug Target Discovery and New Veterinary Drug Creation
Zitieren
APA
Wu, S., Zhang, L., Luo, X., Lin, C., Wan, P., Huang, H., Lu, Y., Tang, Y., & Zeng, Z. (2025). In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf064
Vancouver
Wu S, Zhang L, Luo X, Lin C, Wan P, Huang H, et al. In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf064
BibTeX
@article{Wu2025,
author = {Wu, Sujuan and Zhang, Lu and Luo, Xinyue and Lin, Changcheng and Wan, Peng and Huang, Honghao and Lu, Yixing and Tang, Youzhi and Zeng, Zhenling},
title = {In vitro and in vivo antibacterial activity, resistance analysis and molecular docking study of pleuromutilin derivatives against Streptococcus suis},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2025},
doi = {10.1093/jac/dkaf064}
}
EUVIMED